All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0622-ZP3501 | Anti-αvβ6 h(VHH1-VHH2-4-1BB-CD3ζ) Biepitopic CAR, pCDCAR1 | VHH1-VHH2-4-1BB-CD3ζ | Lentiviral vector | T Cell | |||||
XS-0822-YF9417 | TS-Fluc Anti-Human αvβ6 scFv (XW-919) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-919 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9418 | TS-Fluc Anti-Human αvβ6 scFv (XW-920) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-920 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9826 | TS-IL15 SA Anti-Human αvβ6 scFv (XW-919) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-919 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF9827 | TS-IL15 SA Anti-Human αvβ6 scFv (XW-920) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-920 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF10235 | TS-IL15 SA Anti-Human αvβ6 scFv (XW-919) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-919 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10236 | TS-IL15 SA Anti-Human αvβ6 scFv (XW-920) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-920 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10644 | TS-IL15 SA Anti-Human αvβ6 scFv (XW-919) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-919 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10645 | TS-IL15 SA Anti-Human αvβ6 scFv (XW-920) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-920 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-1122-YF919 | Anti-αvβ6 KIR CAR (scFv-KIR2DS2-DAP12, XW-919), pCDCAR1 | Human | XW-919 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF920 | Anti-αvβ6 KIR CAR (scFv-KIR2DS2-DAP12, XW-920), pCDCAR1 | Human | XW-920 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
XS-1122-YF1839 | Anti-αvβ6 TCR-ABR (scFv-TCRα, XW-919) CAR Plasmid, pCDCAR1 | Human | XW-919 | Mouse | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF1840 | Anti-αvβ6 TCR-ABR (scFv-TCRα, XW-920) CAR Plasmid, pCDCAR1 | Human | XW-920 | Mouse | scFv-TCRα | Lentiviral vector | T Cell | ||
XS-1122-YF2759 | Anti-αvβ6 TCR-ABR (scFv-TCRβ, XW-919) CAR Plasmid, pCDCAR1 | Human | XW-919 | Mouse | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF2760 | Anti-αvβ6 TCR-ABR (scFv-TCRβ, XW-920) CAR Plasmid, pCDCAR1 | Human | XW-920 | Mouse | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-0123-ZP787 | Anti-αvβ6 (Bpep) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | Bpep | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP788 | Anti-αvβ6 (A20(FMDV2)) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | A20(FMDV2) | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP787 | Anti-αvβ6 (Bpep scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | Bpep | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP788 | Anti-αvβ6 (A20(FMDV2) scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | A20(FMDV2) | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0923-LX110 | Anti-hαvβ6 (CD28-41BB-CD3ζ) CAR-duplex CTLA4 pCDCAR1 Vector | Human | X9X-79 | scFv-CD28-41BB-CD3ζ-duplex CTLA4 | Lentiviral vector | T cell | CAR-T |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION